ARTICLE | Company News
ProtoMed other research news
August 10, 1998 7:00 AM UTC
ProtoMed received a $741,000 Phase II SBIR grant from the National Institute of General Medical Sciences to fund a U.S. Phase I/II trial of its protease inhibitor in patients with ulcerative colitis. ...